Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aviad Tsherniak

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Cancer Cell|January 8, 2021
An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment PersistenceEugen Dhimolea, Ricardo de Matos Simoes, Dhvanir Kansara, et al.
Elife|February 9, 2017
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerabilityBrenton R Paolella, William J Gibson, Laura M Urbanski, et al.
Nature|August 10, 2018
Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben-David, Benjamin Siranosian, Gavin Ha, et al.
Nature Genetics|March 23, 2021
A first-generation pediatric cancer dependency mapNeekesh V Dharia, Guillaume Kugener, Lillian M Guenther, et al.
Nature Genetics|September 19, 2018
Mutational processes shape the landscape of TP53 mutations in human cancerAndrew O Giacomelli, Xiaoping Yang, Robert E Lintner, et al.
Cell Reports|October 3, 2019
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven CancersRita Sulahian, Jason J Kwon, Katherine H Walsh, et al.
Nature Genetics|July 13, 2021
Genome-scale screens identify factors regulating tumor cell responses to natural killer cellsMichal Sheffer, Emily Lowry, Nicky Beelen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2011
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancerHiu Wing Cheung, Glenn S Cowley, Barbara A Weir, et al.
Cancer Discovery|June 5, 2016
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J Aguirre, Robin M Meyers, Barbara A Weir, et al.
Cancer Research|February 14, 2019
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsThomas P Howard, Taylor E Arnoff, Melinda R Song, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Cancer Cell|January 8, 2021
An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment PersistenceEugen Dhimolea, Ricardo de Matos Simoes, Dhvanir Kansara, et al.
Elife|February 9, 2017
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerabilityBrenton R Paolella, William J Gibson, Laura M Urbanski, et al.
Nature|August 10, 2018
Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben-David, Benjamin Siranosian, Gavin Ha, et al.
Nature Genetics|March 23, 2021
A first-generation pediatric cancer dependency mapNeekesh V Dharia, Guillaume Kugener, Lillian M Guenther, et al.
Nature Genetics|September 19, 2018
Mutational processes shape the landscape of TP53 mutations in human cancerAndrew O Giacomelli, Xiaoping Yang, Robert E Lintner, et al.
Cell Reports|October 3, 2019
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven CancersRita Sulahian, Jason J Kwon, Katherine H Walsh, et al.
Nature Genetics|July 13, 2021
Genome-scale screens identify factors regulating tumor cell responses to natural killer cellsMichal Sheffer, Emily Lowry, Nicky Beelen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2011
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancerHiu Wing Cheung, Glenn S Cowley, Barbara A Weir, et al.
Cancer Discovery|June 5, 2016
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J Aguirre, Robin M Meyers, Barbara A Weir, et al.
Cancer Research|February 14, 2019
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsThomas P Howard, Taylor E Arnoff, Melinda R Song, et al.
Pageof 7